217 related articles for article (PubMed ID: 30305637)
1. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia.
McMaster ML; Berndt SI; Zhang J; Slager SL; Li SA; Vajdic CM; Smedby KE; Yan H; Birmann BM; Brown EE; Smith A; Kleinstern G; Fansler MM; Mayr C; Zhu B; Chung CC; Park JH; Burdette L; Hicks BD; Hutchinson A; Teras LR; Adami HO; Bracci PM; McKay J; Monnereau A; Link BK; Vermeulen RCH; Ansell SM; Maria A; Diver WR; Melbye M; Ojesina AI; Kraft P; Boffetta P; Clavel J; Giovannucci E; Besson CM; Canzian F; Travis RC; Vineis P; Weiderpass E; Montalvan R; Wang Z; Yeager M; Becker N; Benavente Y; Brennan P; Foretova L; Maynadie M; Nieters A; de Sanjose S; Staines A; Conde L; Riby J; Glimelius B; Hjalgrim H; Pradhan N; Feldman AL; Novak AJ; Lawrence C; Bassig BA; Lan Q; Zheng T; North KE; Tinker LF; Cozen W; Severson RK; Hofmann JN; Zhang Y; Jackson RD; Morton LM; Purdue MP; Chatterjee N; Offit K; Cerhan JR; Chanock SJ; Rothman N; Vijai J; Goldin LR; Skibola CF; Caporaso NE
Nat Commun; 2018 Oct; 9(1):4182. PubMed ID: 30305637
[TBL] [Abstract][Full Text] [Related]
2. Familial aggregation of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia with solid tumors and myeloid malignancies.
Kristinsson SY; Goldin LR; Turesson I; Björkholm M; Landgren O
Acta Haematol; 2012; 127(3):173-7. PubMed ID: 22310551
[TBL] [Abstract][Full Text] [Related]
3. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
4. Rarity of IgH translocations in Waldenström macroglobulinemia.
Ackroyd S; O'Connor SJ; Owen RG
Cancer Genet Cytogenet; 2005 Nov; 163(1):77-80. PubMed ID: 16271961
[TBL] [Abstract][Full Text] [Related]
5. Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Schop RF; Kuehl WM; Van Wier SA; Ahmann GJ; Price-Troska T; Bailey RJ; Jalal SM; Qi Y; Kyle RA; Greipp PR; Fonseca R
Blood; 2002 Oct; 100(8):2996-3001. PubMed ID: 12351413
[TBL] [Abstract][Full Text] [Related]
6. Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families.
McMaster ML; Goldin LR; Bai Y; Ter-Minassian M; Boehringer S; Giambarresi TR; Vasquez LG; Tucker MA
Am J Hum Genet; 2006 Oct; 79(4):695-701. PubMed ID: 16960805
[TBL] [Abstract][Full Text] [Related]
7. MYD88 mutant lymphoplasmacytic lymphoma/Waldenström macroglobulinemia has distinct clinical and pathological features as compared to its mutation negative counterpart.
Patkar N; Subramanian PG; Deshpande P; Ghodke K; Tembhare P; Mascarenhas R; Muranjan A; Chaudhary S; Bagal B; Gujral S; Sengar M; Menon H
Leuk Lymphoma; 2015 Feb; 56(2):420-5. PubMed ID: 24828863
[TBL] [Abstract][Full Text] [Related]
8. Waldenström Macroglobulinemia and Non-IgM-Type Lymphoplasmacytic Lymphoma Are Genetically Similar.
Awata-Shiraiwa M; Yokohama A; Kanai Y; Gotoh N; Kasamatsu T; Handa H; Saitoh T; Murakami H; Hirato J; Ikota H; Tsukamoto N
Acta Haematol; 2023; 146(5):384-390. PubMed ID: 36917966
[TBL] [Abstract][Full Text] [Related]
9. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia.
Kristinsson SY; Koshiol J; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
J Natl Cancer Inst; 2010 Apr; 102(8):557-67. PubMed ID: 20181958
[TBL] [Abstract][Full Text] [Related]
10. Familial Waldenström Macroglobulinemia: Families Informing Populations.
McMaster ML
Hematol Oncol Clin North Am; 2018 Oct; 32(5):787-809. PubMed ID: 30190018
[TBL] [Abstract][Full Text] [Related]
11. Genetics and cytogenetics of Waldenstrom's macroglobulinemia.
Schop RF; Fonseca R
Semin Oncol; 2003 Apr; 30(2):142-5. PubMed ID: 12720124
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.
Roccaro AM; Sacco A; Shi J; Chiarini M; Perilla-Glen A; Manier S; Glavey S; Aljawai Y; Mishima Y; Kawano Y; Moschetta M; Correll M; Improgo MR; Brown JR; Imberti L; Rossi G; Castillo JJ; Treon SP; Freedman ML; Van Allen EM; Hide W; Hiller E; Rainville I; Ghobrial IM
Blood; 2016 May; 127(21):2598-606. PubMed ID: 26903547
[TBL] [Abstract][Full Text] [Related]
14. [Chromosomal abnormalities and Waldenström macroglobulinemia].
Berger R; Nguyen-Khac F
Pathol Biol (Paris); 2008 Sep; 56(6):400-6. PubMed ID: 18456427
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
Cerhan JR; Berndt SI; Vijai J; Ghesquières H; McKay J; Wang SS; Wang Z; Yeager M; Conde L; de Bakker PI; Nieters A; Cox D; Burdett L; Monnereau A; Flowers CR; De Roos AJ; Brooks-Wilson AR; Lan Q; Severi G; Melbye M; Gu J; Jackson RD; Kane E; Teras LR; Purdue MP; Vajdic CM; Spinelli JJ; Giles GG; Albanes D; Kelly RS; Zucca M; Bertrand KA; Zeleniuch-Jacquotte A; Lawrence C; Hutchinson A; Zhi D; Habermann TM; Link BK; Novak AJ; Dogan A; Asmann YW; Liebow M; Thompson CA; Ansell SM; Witzig TE; Weiner GJ; Veron AS; Zelenika D; Tilly H; Haioun C; Molina TJ; Hjalgrim H; Glimelius B; Adami HO; Bracci PM; Riby J; Smith MT; Holly EA; Cozen W; Hartge P; Morton LM; Severson RK; Tinker LF; North KE; Becker N; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; Lightfoot T; Crouch S; Smith A; Roman E; Diver WR; Offit K; Zelenetz A; Klein RJ; Villano DJ; Zheng T; Zhang Y; Holford TR; Kricker A; Turner J; Southey MC; Clavel J; Virtamo J; Weinstein S; Riboli E; Vineis P; Kaaks R; Trichopoulos D; Vermeulen RC; Boeing H; Tjonneland A; Angelucci E; Di Lollo S; Rais M; Birmann BM; Laden F; Giovannucci E; Kraft P; Huang J; Ma B; Ye Y; Chiu BC; Sampson J; Liang L; Park JH; Chung CC; Weisenburger DD; Chatterjee N; Fraumeni JF; Slager SL; Wu X; de Sanjose S; Smedby KE; Salles G; Skibola CF; Rothman N; Chanock SJ
Nat Genet; 2014 Nov; 46(11):1233-8. PubMed ID: 25261932
[TBL] [Abstract][Full Text] [Related]
16. Elevated risk of venous but not arterial thrombosis in Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
Hultcrantz M; Pfeiffer RM; Björkholm M; Goldin LR; Turesson I; Schulman S; Landgren O; Kristinsson SY
J Thromb Haemost; 2014 Nov; 12(11):1816-21. PubMed ID: 25196979
[TBL] [Abstract][Full Text] [Related]
17. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
[TBL] [Abstract][Full Text] [Related]
18. Lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia: an evolving concept.
Lin P; Medeiros LJ
Adv Anat Pathol; 2005 Sep; 12(5):246-55. PubMed ID: 16210920
[TBL] [Abstract][Full Text] [Related]
19. Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia.
Wang Y; Gali VL; Xu-Monette ZY; Sano D; Thomas SK; Weber DM; Zhu F; Fang X; Deng M; Zhang M; Hagemeister FB; Li Y; Orlowski RZ; Lee HC; Young KH
Neoplasia; 2021 Apr; 23(4):361-374. PubMed ID: 33735664
[TBL] [Abstract][Full Text] [Related]
20. Two case reports of non-secretory [correction of non-secretary]-Ig types of lymphoplasmacytic lymphoma (LPL).
Kobayashi K; Yokote T; Hirata Y; Nakayama S; Hiraoka N; Takayama A; Iwaki K; Akioka T; Takubo T; Tsuji M; Hanafusa T
Ann Hematol; 2010 Sep; 89(9):945-7. PubMed ID: 20107989
[No Abstract] [Full Text] [Related]
[Next] [New Search]
